Table 3.
MDACC Multivariable Models
Comparative Variable | Multivariable Analyses by Survival Status |
|||||
---|---|---|---|---|---|---|
Recurrence Free |
Distant Recurrence–Free |
|||||
Hazard Ratio | 95% CI | P | Hazard Ratio | 95% CI | P | |
HER2 status | ||||||
Positive v negative | 2.68 | 1.44 to 5 | .002 | 5.30 | 2.23 to 12.62 | .0002 |
Hormone receptor status | ||||||
Positive v negative | 0.41 | 0.23 to 0.72 | .002 | 0.59 | 0.25 to 1.37 | .219 |
Age at diagnosis, years* | 0.96 | 0.94 to 0.98 | .001 | 0.73 | 0.32 to 1.7 | .467 |
Tumor grade | ||||||
3 v 1-2 | 1.34 | 0.75 to 2.41 | .320 | 0.97 | 0.94 to 1 | .080 |
Stage | ||||||
Ib v Ia | 1.59 | 0.91 to 2.78 | .103 | 1.47 | 0.68 to 3.18 | .329 |
Abbreviations: MDACC, M. D. Anderson Cancer Center; HER2, human epidermal growth factor receptor 2.
Continuous variable.